nanjappa a's most recent trade in Kabra Drugs Ltd. was a Acquisition of 658,500 Equity Shares done at an average price of Rs. 10 . Disclosure was reported to the exchange on Sept. 24, 2024 under the SEBI (Prohibition of Insider Trading) Regulations, 2015.
nanjappa a's has made SAST transactions in Kabra Drugs Ltd. recently where a Acquisition of 658,500 shares done . Disclosure was reported to the exchange on Sept. 20, 2024.
Stock | Client Name | Client Category | Action* | Reported To/By Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Period | Regulation (Insider/SAST) | Security Type | Mode |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Kabra Drugs | Kuniamuthur Nanjappan Anand | Other | Acquisition | 08 Oct 2024 | 658,500 | 658,500 (6.53%) | 6.53% | - | 16 Aug 2024 16 Aug 2024 |
SAST (29(1)) | - | Pref. Allotment | |
Kabra Drugs | Kuniamuthur Nanjappan Anand | Other | Acquisition | 08 Oct 2024 | 658,500 | 658,500 (6.53%) | 6.53% | - | 05 Jul 2024 05 Jul 2024 |
SAST (29(1)) | - | Pref. Allotment | |
Kabra Drugs | Kuniamuthur Nanjappan Anand (Revised) | Director | Acquisition | 24 Sep 2024 | 658,500 | 658,500 (6.53%) | 15.00% | 10 | 6,585,000 | 16 Aug 2024 16 Aug 2024 |
Insider Trading | Equity Shares | Preferential Offer |
Kabra Drugs | Kuniamuthur Nanjappan Anand | Director | Acquisition | 24 Sep 2024 | 658,500 | 658,500 (6.53%) | 15.00% | 0.0 | 7 | 16 Aug 2024 16 Aug 2024 |
Insider Trading | Equity Shares | Preferential Offer |